B -- EARLY DETECTION RESEARCH NETWORK (EDRN) CONTINUATION OF CERVIAL CANCER STUDY AT GRADY MEMORIAL HOSPITAL

Notice Date

June 20, 2001

Contracting Office

Department of Health and Human Services, Center for Disease Control and Prevention, Procurement and Grants Office (Atlanta), 2920 Brandywine Road, Room 3000, Atlanta, GA, 30341-4146

ZIP Code

30341-4146

Solicitation Number

2001-N-00123

Response Due

August 15, 2001

Point of Contact

Susan Kiddoo, Contract Specialist, Phone (770)488-2605, Fax (770)488-2670, Email SKiddoo@CDC.GOV

Description

The Centers for Disease Control and Prevention (CDC) intends to award a contract on a sole source basis to Emory University School of Medicine, 1639 Pierce Drive, Atlanta, GA 30322 to continue administration of the clinical and epidemiologic components of CDC's Early Detection Research Network (EDRN) study of cervical cancer that is being conducted at Grady Memorial Hospital Health Care System in Atlanta, GA. The administrative objectives are to continue the recruitment and enrollment of eligible women, to ensure safe and proper clinical evaluation and sample collection, and to collect and accurately record all patient and epidemiologic information required for the study. The project is a study of preinvasive cervical lesions in a high-risk urban population of women. To be considered eligible for this acquisition, Offerors must meet the following absolute eligibility criteria: (1) be a public or private academic institution, medical center, or health department with clinical responsibility for the gynecologic clinics at Grady Memorial Hospital in Atlanta, GA; (2) have permission to approach Grady Memorial Hospital patients for recruitment and enrollment into clinical studies; (3) have access to the clinical records of patients at Grady Memorial Hospital; (4) demonstrate access to a patient population in which the Offeror can reasonably predict ability to identify, and recruit into the study 7 women with dysplasia and 7 race and age matched control women each week for up to three years and (5) provide colposcopic directed biopsy confirmation of cervical lesions for all women with dysplasia by loaning pathology slides to CDC for review. The SIC code for this requirement is 8069. The NAICS code for this requirement is 622110. The scheduled issued date is approximately July 10, 2001. Other than full and open competition is authorized pursuant to 41 U.S.C. 2253 (c)(1). QUALIFIED OFFERORS HAVE 14 DAYS FROM THE DATE OF THIS SYNOPSIS TO SUMBIT CAPABILITY STATEMENTS DELINEATING THEIR ABILITY TO PERFORM THIS STUDY. Such qualifications will be used solely for the purpose of determining whether or not to conduct this procurement on a full and open competition basis. No telephone requests will be accepted; ONLY WRITTEN RESPONSES, WHETHER BY EMAIL, , FAX, OR MAIL WILL BE HONORED. Capability statement for this requirement may be emailed to Susan Kiddoo at skiddoo@cdc.gov or faxed to (770) 488-2670 or 2671. Please cite RFP No. 2001-N-00123 in the subject line, and include your name, mailing address, phone number, and email address.

Web Link

Visit this URL for the latest information about this (http://www.eps.gov/spg/HHS/CDCP/PGOA/2001-N-00123/listing.html)

Record

Loren Data Corp. 20010622/BSOL010.HTM (D-171 SN50P4V4)